Heron Therapeutics, Inc. · Transaction Mar 31, 2021 · Filed Apr 5, 2021 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · HRTX
-0.53% · $0.0000 · Vol Not reported
Pre-market · updated 07:38:34 ET
Heron Therapeutics Inc
Biotechnology
$0.3540
Follow $HRTX
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $HRTX by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredThu Oct 1 · last completed session · Pre-market · regular session opens 9:30 ET · HRTX
MethodologySentiment absence reason unknown
HRTX
Heron Therapeutics Inc
Thu Oct 1 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
49/ 100
Veridion Score
Middle range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Thu Oct 1 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is HRTX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Heron Therapeutics Inc
PHARMACEUTICAL PREPARATIONSListed since
1987
Employees
128
Country
US
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$0.3559
Last session
Day high
$0.3559
Last session
Day low
$0.3559
Last session
Previous close
$0.3559
52W high
$1.49
-76.24% from high
52W low
$0.2700
7% of range
Market cap
$67.6M
EPS
$-0.1900
Beta
0.68
Shares out
189.9M
Avg volume
2.2M
VWAP
$0.3559
Last session
Price history computed in-house
1W
+20.33%
1M
+13.14%
3M
-19.25%
1Y
-72.77%
YTD
-72.77%
SMA 50 $0.3588 · below
SMA 200 $0.8039 · below
52W position 7%
HRTX overview
Related filings and maps
Public disclosures
Congress activity in HRTX
Official filing ↗
Federal contracts
HRTX contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HRTX in this window.
Lobbying spend
HRTX lobbying filings, year to date.
Registered lobbying filings matched to Heron Therapeutics Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HRTX in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for HRTX.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.